Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.43 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1235817 | 1.00 | PTGS1 (0.43) | PTGS1SLC7A11ENPEP | |
| SCHEMBL5074148 | 0.88 | PTGS1 (0.56) | PTGS1SLC7A11ENPEP | |
| SCHEMBL20657045 | 0.87 | PTGS1 (0.55) | PTGS1SLC7A11ENPEP | |
| SCHEMBL1964879 | 0.87 | PTGS1 (0.55) | PTGS1SLC7A11ENPEP | |
| SCHEMBL11053743 | 0.86 | PTGS1 (0.39) | PTGS1SLC7A11 | |
| SCHEMBL1236281 | 0.86 | PTGS1 (0.39) | PTGS1SLC7A11 | |
| Hydrochloric Acid SCHEMBL11053789 | 0.84 | PTGS1 (0.52) | PTGS1SLC7A11ENPEP | |
| Hydrochloric Acid SCHEMBL11053790 | 0.84 | PTGS1 (0.52) | PTGS1SLC7A11ENPEP | |
| SCHEMBL1065404 | 0.83 | PTGS1 (0.48) | PTGS1SLC7A11ENPEP | |
| SCHEMBL6147913 | 0.83 | PTGS1 (0.43) | PTGS1SLC7A11ENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112011499-B | Method for preparing extracellular vesicles and application thereof | 徐州医科大学 | 2022-06-03 | — | — | CN | claimed |
| CN-113181175-A | Application of epalrestat as inhibitor for specifically targeting NLRP3 inflammatory bodies | 中国人民解放军总医院第五医学中心 | 2021-07-30 | — | — | CN | claimed |
| CN-109536546-B | Preparation method and application of medium-small molecular weight oat beta-glucan | 上海晟薇生物科技有限公司 | 2021-03-19 | — | — | CN | claimed |
| CN-112294828-A | Use of cryptotanshinone as inflammation inhibitor | 中国人民解放军总医院第五医学中心 | 2021-02-02 | — | — | CN | claimed |
| CN-112011499-A | Method for preparing extracellular vesicles and application thereof | 徐州医科大学 | 2020-12-01 | — | — | CN | claimed |
| CN-107137724-B | Material for constructing temperature-responsive aggregate in cell and preparation method and application thereof | 国家纳米科学中心 | 2020-11-10 | — | — | CN | claimed |
| CN-110638861-A | Application of composition in skin barrier gene repair | 上海珈凯生物科技有限公司 | 2020-01-03 | — | — | CN | claimed |
| CN-108601764-A | Compounds and methods for enhanced degradation of target proteins | 阿尔维纳斯股份有限公司 | 2018-09-28 | — | — | CN | claimed |
| CN-107137724-A | A kind of intracellular material for constructing temperature-responsive aggregation and its preparation method and application | 国家纳米科学中心 | 2017-09-08 | — | — | CN | claimed |
| CN-105765067-A | Modified beta-galactosidase | 天野酶株式会社 | 2016-07-13 | — | — | CN | claimed |
| US-20060212020-A1 | Sample collection system with caspase inhibitor | BECTON, DICKINSON AND COMPANY | 2006-09-21 | — | — | US | claimed |
| EP-1549224-A1 | SAMPLE COLLECTION SYSTEM WITH CASPASE INHIBITOR | Becton Dickinson and Company (US) | 2005-07-06 | — | — | EP | claimed |
| WO-2004032750-A1 | SAMPLE COLLECTION SYSTEM WITH CASPASE INHIBITOR | BECTON DICKINSON AND COMPANY (US) | 2004-04-22 | — | — | WO | claimed |
| US-4632703-A | SULFONATED PHTHALOCYANINE DYE; ESPECIALLY FOR INK JET PRINTING | CANON KABUSHIKI KAISHA (JP) | 1986-12-30 | — | — | US | claimed |
| EP-4695265-A1 | METHOD AND COMPOSITION FOR OLIGONUCLEOTIDE SYNTHESIS | Bachem Holding AG (CH) | 2026-02-18 | — | — | EP | disclosed |
| EP-4605403-B1 | METHOD AND COMPOSITION FOR OLIGONUCLEOTIDE SYNTHESIS | BACHEM HOLDING AG (CH) | 2025-11-26 | — | — | EP | disclosed |
| EP-4605403-A1 | METHOD AND COMPOSITION FOR OLIGONUCLEOTIDE SYNTHESIS | Bachem Holding AG (CH) | 2025-08-27 | — | — | EP | disclosed |
| WO-1999052925-A1 | PROGRAMMED CELL DEATH AND CASPASE-12 | THE GENERAL HOSPITAL CORPORATION (US) | 1999-10-21 | — | — | WO | disclosed |
| WO-1999018230-A2 | METHOD TO DETECT MRIT AND BCL-2 OR CASPASE ASSOCIATION ALTERATIONS | UNIVERSITY OF WASHINGTON (US) | 1999-04-15 | — | — | WO | disclosed |
| WO-1998055863-A1 | RAPID METHODS FOR IDENTIFYING MODIFIERS OF CELLULAR APOPTOSIS ACTIVITY | IDUN PHARMACEUTICALS, INC. (US) | 1998-12-10 | — | — | WO | disclosed |